Laudanum of opium tincture prevails today only because opium tincture was sold prior to the Federal Food, Drug & Cosmetic Act of 1938. Its "grandfathered" status protects opium tincture from being required to undergo strict FDA drug reviews and subsequent approval processes. However, the FDA closely monitors the labeling of opium tincture. Bottles of opium tincture are required by the FDA to bear a bright red "POISON" label given the potency of the drug and the potential for overdose (see discussion about confusion with Paregoric below). Despite opium tincture being an "unapproved drug" as discussed above, a search of FDA's website
Pennsylvania Department of Drug and Alcohol Programs has been proven successful to those trying to remedy their addictions. DDAP provides access to programs such as the prescription drug take back program, overdose awareness, and information on rehab centers. One of their main projects, is to spread the knowledge and availability of Naloxone, which is a medication that can reverse an overdose caused by an Opioid drug overdose. They have made progress on this front by enacting ACT 139, which gives first responders, friends, and families access to the opioid overdose reversal medicine, this way more lives can be saved by a quicker treatment response. Within the United